Ypsomed Holding (SWX:YPSN) - Prezzo delle azioni, notizie e analisi

YPSN Panoramica delle azioni

Ypsomed Holding AG, insieme alle sue controllate, sviluppa, produce e vende sistemi di iniezione e infusione per aziende farmaceutiche e biotecnologiche. Maggiori dettagli

YPSN analisi fondamentale
Punteggio fiocco di neve
Valutazione	3/6
Crescita futura	5/6
Prestazioni passate	2/6
Salute finanziaria	5/6
Dividendi	0/6

Premi

Negoziato a 34.4% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 40.64% all'anno

Gli utili sono cresciuti del 2.7% nell'ultimo anno

Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 20.3%

Analisi del rischio

Elevato livello di guadagni non monetari

Prezzo delle azioni volatile negli ultimi 3 mesi

Ypsomed Holding AG Concorrenti

Alcon

SWX:ALC

CHF 37.8b

IVF Hartmann Holding

SWX:VBSN

CHF 347.7m

COLTENE Holding

SWX:CLTN

CHF 305.9m

Medacta Group

SWX:MOVE

CHF 2.2b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Ypsomed Holding
Prezzi storici delle azioni
Prezzo attuale dell'azione	CHF 358.00
Massimo di 52 settimane	CHF 439.00
Minimo di 52 settimane	CHF 273.50
Beta	0.97
1Variazione di 1 mese	-12.90%
Variazione a 3 mesi	-12.25%
Variazione di 1 anno	27.18%
3Variazione a 3 anni	96.27%
Variazione a 5 anni	162.85%
Variazione dall'IPO	383.78%

Notizie e aggiornamenti recenti

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Nov 17

Recent updates

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Nov 17

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

May 08

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Apr 07

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Mar 09

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

Feb 07

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Jan 17

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Dec 27

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Nov 24

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Oct 19

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Jul 14

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jun 20

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Feb 28

Rendimenti per gli azionisti

	YPSN	CH Medical Equipment	CH Mercato
7D	-13.3%	-5.2%	-2.2%
1Y	27.2%	13.8%	6.2%

Ritorno vs Industria: YPSN ha superato il Swiss Medical Equipment che ha restituito 13.8 % nell'ultimo anno.

Rendimento vs Mercato: YPSN ha superato il mercato Swiss che ha restituito 6.2 % nell'ultimo anno.

Volatilità dei prezzi

Is YPSN's price volatile compared to industry and market?
YPSN volatility
YPSN Average Weekly Movement	4.6%
Medical Equipment Industry Average Movement	3.9%
Market Average Movement	3.3%
10% most volatile stocks in CH Market	6.6%
10% least volatile stocks in CH Market	1.6%

Prezzo delle azioni stabile: Il prezzo delle azioni di YPSN è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di YPSN è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni Swiss.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1984	2,296	Simon Michel	www.ypsomed.com

Ypsomed Holding AG, insieme alle sue controllate, sviluppa, produce e vende sistemi di iniezione e infusione per aziende farmaceutiche e biotecnologiche. L'azienda opera attraverso due segmenti, Ypsomed Delivery Systems e Ypsomed Diabetes Care. Il segmento Ypsomed Delivery Systems fornisce vari sistemi di iniezione, come iniettori a penna, autoiniettori e iniettori indossabili, oltre ad altri dispositivi intelligenti.

Ypsomed Holding AG Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Ypsomed Holding con la sua capitalizzazione di mercato?
YPSN statistiche fondamentali
Capitalizzazione di mercato	CHF 4.89b
Guadagni(TTM)	CHF 74.39m
Ricavi(TTM)	CHF 617.07m

65.7x

Rapporto P/E

7.9x

Rapporto P/S

YPSN è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
YPSN Conto economico (TTM)
Ricavi	CHF 617.07m
Costo del fatturato	CHF 398.41m
Profitto lordo	CHF 218.66m
Altre spese	CHF 144.28m
Guadagni	CHF 74.39m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	5.45
Margine lordo	35.44%
Margine di profitto netto	12.05%
Rapporto debito/patrimonio netto	0%

Come si è comportato YPSN nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.6%

Rendimento attuale del dividendo

37%

Rapporto di remunerazione

YPSN Panoramica delle azioni

Premi

Analisi del rischio

Ypsomed Holding AG Concorrenti

SWX:ALC

CHF 37.8b

SWX:VBSN

CHF 347.7m

SWX:CLTN

CHF 305.9m

SWX:MOVE

CHF 2.2b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

New minor risk - Share price stability

Ypsomed Group and CamDiab Receives Health Canada Approval for mylife YpsoPump and CamAPS FX and Provide an Enhancing Diabetes Management

Now 23% undervalued

Now 21% undervalued

Ypsomed Holding AG to Report First Half, 2025 Results on Nov 13, 2024

Recent updates

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

New minor risk - Share price stability

Ypsomed Group and CamDiab Receives Health Canada Approval for mylife YpsoPump and CamAPS FX and Provide an Enhancing Diabetes Management

Now 23% undervalued

Now 21% undervalued

Ypsomed Holding AG to Report First Half, 2025 Results on Nov 13, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Price target increased by 7.6% to CHF378

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Full year 2024 earnings released: EPS: CHF5.74 (vs CHF3.82 in FY 2023)

Investor sentiment improves as stock rises 17%

Ypsomed Holding AG to Report Q4, 2024 Results on May 22, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Price target increased by 14% to CHF365

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?

First half 2024 earnings released: EPS: CHF2.68 (vs CHF1.17 in 1H 2023)

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Price target increased by 14% to CHF315

Ypsomed Holding AG to Report First Half, 2024 Results on Nov 15, 2023

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital

Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?

Ypsomed Holding AG, Annual General Meeting, Jun 26, 2024

Upcoming dividend of €1.30 per share at 0.5% yield

Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?

Consensus EPS estimates increase by 15%

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Price target increased by 13% to CHF257

Ypsomed Holding AG to Report Fiscal Year 2023 Results on May 24, 2023

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital

Ypsomed Holding AG, Annual General Meeting, Jun 28, 2023

At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Price target increased to CHF223

Mediq B.V. completed the acquisition of DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN).

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Investor sentiment deteriorated over the past week

Now 21% undervalued

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Consensus forecasts updated

Price target increased to CHF207

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

No independent directors

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Price target decreased to CHF192

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching